These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2889345)

  • 21. Therapeutic effect on left ventricular hypertrophy by different antihypertensive drugs.
    Motz W; Strauer BE
    Clin Investig; 1992; 70 Suppl 1():S87-92. PubMed ID: 1534267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adrenergic mechanisms in left ventricular hypertrophy: significance and clinical implications.
    Ram CV
    Indian Heart J; 1993; 45(1):21-4. PubMed ID: 8103506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regression of left ventricular hypertrophy and control of hypertension in the spontaneously hypertensive rat (SHR): oxprenolol versus hydrochlorothiazide.
    Idikio H; Fernandez PG; Triggle CR; Kim BK
    Clin Invest Med; 1983; 6(1):43-8. PubMed ID: 6219850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systolic and diastolic function following regression of left ventricular hypertrophy in hypertension.
    Balogun MO; Dunn FG
    J Hypertens Suppl; 1991 Dec; 9(2):S51-5. PubMed ID: 1838768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of sympathetic nervous activity on regression of cardiac hypertrophy.
    Strauer BE; Bayer F; Brecht HM; Motz W
    J Hypertens Suppl; 1985 Dec; 3(4):S39-44. PubMed ID: 2937889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Left Ventricular Hypertrophy in Hypertensive Athletes can be Reduced by Antihypertensive Medication Despite Continuing Intense Aerobic Exercise.
    Ketelhut S; Franz IW; Ketelhut RG
    High Blood Press Cardiovasc Prev; 2018 Dec; 25(4):385-390. PubMed ID: 30341642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Possible regression of left ventricular hypertrophy during antihypertensive treatment with diuretics and/or beta blockers.
    Cherchi A; Sau F; Seguro C
    J Clin Hypertens; 1987 Jun; 3(2):216-25. PubMed ID: 2886561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Considerations in treating hypertension: focus on risk factors.
    Messerli FH
    J Hum Hypertens; 1990 Dec; 4 Suppl 5():3-6. PubMed ID: 2151045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of indapamide on left ventricular mass and function in systemic hypertension with left ventricular hypertrophy.
    Komajda M; Klimczak K; Boutin B; Brackman F; Guez D; Grosgogeat Y
    Am J Cardiol; 1990 May; 65(17):37H-42H. PubMed ID: 2139541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of antihypertensive agents on the left ventricle: clinical implications.
    Díez J; González A; López B; Ravassa S; Fortuño MA
    Am J Cardiovasc Drugs; 2001; 1(4):263-79. PubMed ID: 14728026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is the decrease in arterial pressure the sole factor for reduction of left ventricular hypertrophy?
    Schmieder RE; Messerli FH
    Am J Med; 1992 Apr; 92(4B):28S-34S. PubMed ID: 1533746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adrenergic activity and myocardial anatomy and function in essential hypertension.
    Muiesan G; Agabiti-Rosei E; Muiesan ML
    J Hypertens Suppl; 1985 Dec; 3(4):S45-50. PubMed ID: 3007705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Left ventricular hypertrophy and antihypertensive therapy.
    Messerli FH; Oren S; Grossman E
    Drugs; 1988; 35 Suppl 5():27-33. PubMed ID: 2975215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of salt loading and various therapies on cardiac hypertrophy and fibrosis in young spontaneously hypertensive rats.
    Ziegelhöffer-Mihalovicova B; Arnold N; Marx G; Tannapfel A; Zimmer HG; Rassler B
    Life Sci; 2006 Jul; 79(9):838-46. PubMed ID: 16624325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does the ADMA/DDAH/NO pathway modulate early regression of left ventricular hypertrophy with esmolol?
    Quintana-Villamandos B; Delgado-Baeza E
    Med Hypotheses; 2016 Feb; 87():44-7. PubMed ID: 26826640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathophysiology and clinical aspects of hypertensive hypertrophy.
    Vogt M; Motz WH; Schwartzkopf B; Strauer BE
    Eur Heart J; 1993 Jul; 14 Suppl D():2-7. PubMed ID: 8103741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amlodipine and atorvastatin improved hypertensive cardiac hypertrophy through regulation of receptor activator of nuclear factor kappa B ligand/receptor activator of nuclear factor kappa B/osteoprotegerin system in spontaneous hypertension rats.
    Lu J; Liu F; Liu D; Du H; Hao J; Yang X; Cui W
    Exp Biol Med (Maywood); 2016 Jun; 241(11):1237-49. PubMed ID: 26908571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Left ventricular remodeling and hypertension. Course with antihypertensive therapy].
    Ollivier JP
    Arch Mal Coeur Vaiss; 1991 Dec; 84 Spec No 4():73-7. PubMed ID: 1838922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Regression of hypertrophy following nitrendipine: effect on systolic and diastolic function].
    Vogt M; Kreutz KU; Motz W; Strauer BE
    Z Kardiol; 1989 Jul; 78(7):469-77. PubMed ID: 2528245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.